Objective: To assess breastfeeding modes and determinants in a prevention of mother-to-child transmission study.
INTRODUCTION
Optimal infant feeding options for HIV-1-infected mothers in less developed countries has been an object of debate in the scientific community for several decades. 1 Indeed, the risk of mother-to-child transmission (MTCT) of HIV-1 through breast milk [2] [3] [4] needs to be weighed against the risks of malnutrition, severe infectious disease, and death among nonbreastfed infants, which are well documented for resource-poor settings. [5] [6] [7] In sub-Saharan Africa, total avoidance of breastfeeding is particularly difficult to implement. Main reasons are the strong cultural attachment to breastfeeding, 8, 9 widespread poverty, low levels of health care, and high levels of infant and young child mortality. 10 The Kesho Bora randomized controlled trial (RCT) was designed to assess the efficacy and safety of a 3-drug antiretroviral (ARV) regimen compared with zidovudine plus single-dose nevirapine for the prevention of MTCT of HIV-1 during pregnancy, delivery, and breastfeeding for women with CD4 counts between 200 and 500 cells per cubic millimeter. 11 Women with CD4 counts less than 200 or greater than 500 cells per cubic millimeter were offered enrollment into observational cohorts. 11 Women were counseled to either breastfeed exclusively up to 6 months or formula feed from birth.
The objectives of this article were to describe infant feeding modes and to analyze determinants of breastfeeding initiation, modes, and duration within the Kesho Bora Study, including early postpartum health indicators.
MATERIALS AND METHODS

The Kesho Bora Study
The rationale and methods of the Kesho Bora Study have been reported in detail elsewhere. 11 Briefly, the study comprised 1 RCT and 2 prospective cohort studies. Pregnant HIV-1-infected women at less than 32-week gestation, World Health Organization (WHO) clinical stage 1, 2, or 3 disease, and a CD4 count of 200-500 cells per cubic millimeter were eligible for inclusion in the RCT. The intervention group received a combination of 3 ARVs from 28-to 36-week pregnancy up to 6.5 months postpartum (or breastfeeding cessation, if earlier). The control group and cohort B (CD4 count . 500 cells/mm 3 ) received zidovudine from 28-to 36-week and 34-to 36-week pregnancy, respectively, and 1 dose of zidovudine and nevirapine during labor, with 1 week of zidovudine postpartum (from December 2006). Cohort A (CD4 count , 200 cells/mm 3 ) received antiretroviral therapy as per WHO recommendations from enrollment.
The Kesho Bora Study was conducted in 3 sub-Saharan African countries: Bobo-Dioulasso, Burkina Faso (West Africa), Nairobi and Mombasa, Kenya (East Africa), and Durban and a rural and semiurban area of KwaZulu-Natal (Somkhele), Republic of South Africa. These settings were selected according to a number of criteria including ongoing MTCT prevention interventions and breastfeeding initiation rates in HIV-infected women above 50%. 11, 12 In the South African sites, only women eligible for the RCT were enrolled.
Ethical clearance for the study was given by the ethical and regulatory committees in Burkina Faso, Kenya, and South Africa and at the WHO and the US Centers for Disease Control and Prevention. The study was conducted in accordance with the Helsinki Declaration of 1975, as revised in 2000. All women provided written consent. The RCT was registered with Current Controlled Trials, ISRCTN71468401.
Infant feeding counseling was conducted by welltrained study staff (social scientists also collecting infant feeding data in Bobo-Dioulasso and nurses with no involvement in data collection at other sites). Seven antenatal study visits were conducted, 3 of which depended on infant feeding choice (breastfeeding or formula feeding). Postnatal support and counseling was provided at each planned visit until 6 months postpartum (n = 7) following the 2003 WHO guidelines. 13 Extensive counseling materials (flip charts) were available. For breastfeeding women, the importance of exclusive breastfeeding (EBF) was emphasized and optimal breastfeeding techniques were explained. Demonstrations of formula preparations were performed. Free formula was provided for never breastfeeding infants from birth until 6 months of age and from complete cessation till 6 months for weaned infants. In Bobo-Dioulasso, a specifically formulated infant food was provided free of charge from 6 to 12 months. 14 In some sites, breastfeeding women received free food aid (fortified mix in Mombasa and food parcels in South African sites) until complete breastfeeding cessation.
Infant feeding data were collected during the early neonatal period (ie, up to 7 days postpartum) and at 2, 4, 6, and 8 weeks postpartum and thereafter at monthly intervals up to 12 months. Breastfeeding patterns were investigated on the basis of recall (at least once since the preceding visit) for 10 items [breast milk, water or glucose water, tea or juice, formula, other nonhuman milk, porridge (home prepared or commercial), mashed vegetables or fruits, all other foods, gripe water, pharmaceutical drugs, and traditional medicine]. 12 When a woman declared having stopped breastfeeding completely, a specific form was used to recall dates of onset of weaning and complete cessation.
Maternal height was measured to the nearest 0.001 m at inclusion, and weight measurements were taken at all planned visits using electronic scales (Seca 770; Seca, Hamburg, Germany) precise to the nearest 0.1 kg. Socioeconomic and other background data were collected at inclusion by interview (partner disclosure of HIV infection was not collected in South African sites), and CD4 cell count was measured. Data on infant birth weight, sex, and mode of delivery (vaginal, elective, or emergency cesarean delivery) were collected shortly after delivery from hospital files (birth weight was missing for home deliveries). Serious adverse events, including hospitalizations, were noted on specific forms. 15 HIV infection status of infants was assessed by polymerase chain reaction at age 6 weeks (and also at 5 months in South African sites).
Study Population and Definition of Variables for This Analysis
Women who delivered a liveborn singleton infant (or the firstborn of a multiple gestation pregnancy) and who had attended at least 1 study visit after delivery were included.
A wealth indicator was constructed using multiple correspondence analysis of variables related to household characteristics (fuel used for cooking, drinking water source, availability of electricity, possession of radio, television, refrigerator, phone, type of toilets, and sharing of toilet with other households) and divided into tertiles.
Neonatal morbidity was coded as present in case of fever, acute or chronic diarrhea (2 weeks or more), or vomiting since the preceding visit, as reported at the 2-and 4-week visits. For mothers, early postpartum morbidity was coded as present in case of reports of fever or severe fatigue at either of these 2 visits. Maternal early postpartum weight gain was defined as the difference between weights at the 4-and 2-week visits and was classified into tertiles. Maternal body mass index (weight/height 2 ) was computed for the 4-week visit and categorized (underweight, normal, overweight, obese for body mass index , 18.5, 18.5-25, $25 to 30, and $30 kg/m 2 , respectively). Two-week visits conducted before 8 days or after 20 days were considered as missing, as were 4-week visits conducted before 21 days or after 34 days of life. Morbidity was coded as missing if both visits had been missed, and maternal weight gain was missing if any of the 2 visits had been missed.
Statistical Analysis
The analysis considered infant feeding data collected up till age 7 months for the classification of breastfeeding mode and age 12 months for breastfeeding duration. Breastfeeding mode was coded as exclusive, predominant, or partial since the preceding visit. EBF was defined as no foods or fluids other than breast milk, except for modern medicine and vitamin drops. Predominant breastfeeding included breast milk and other fluids (water, sugar water, tea, and juice), whereas partial breastfeeding included breast milk plus other fluids and/or foods, including formula.
First, a "cross-sectional" infant feeding category was created for each visit based on data available for that visit. Second, a "longitudinal" variable was created for each visit based on data available from all visits up to that age. Only infants exclusively breastfed at all visits since birth were considered as exclusively breastfed. If any feeding with fluids other than breastfeeding was recorded for the period since the preceding visit, the infant was moved to the predominantly breastfed category without any possibility of "return" to EBF at later visits. Hereafter, breastfeeding categories refer to the longitudinal definition.
Breastfeeding duration was computed as the difference between the date of complete breastfeeding cessation (as per the breastfeeding cessation form) and the date of birth. If the breastfeeding cessation form was missing (z10% of infants), we used the date of the last visit at which breastfeeding was reported to have occurred in the interval since the preceding visit. A few discrepancies between the 2 estimates were resolved by inspection of data. The end of EBF was estimated as the midpoint between the last visit, at which breastfeeding was still exclusive, and the subsequent visit.
Determinants of breastfeeding initiation and cessation by 3 months were investigated using multiple logistic regression analysis. The probability of ever breastfeeding was examined using all available socioeconomic and healthrelated variables for the time until delivery, including CD4 cell count, trial arm (for the subset of women included in the RCT), birth weight category, and mode of delivery. Three multivariate models were tested: model 1 included household characteristics important for safe preparation of breast milk substitutes (ie, drinking water supply, fuel for cooking, and toilet facility), whereas in model 2, these variables were replaced by the wealth index tertile. Model 3 used only women from Bobo-Dioulasso, Mombasa, and Kenya to introduce the partner disclosure variable.
Determinants of still breastfeeding by 3 months postpartum included only women still breastfeeding by 1 month to test for association with neonate-related variables (ie, neonatal and maternal morbidity and early postpartum maternal weight change) while avoiding reverse causality. Finally, we also conducted a multivariate analysis of determinants of still being exclusively breastfed by 3 months, if exclusively breastfed by 1 month.
For multivariate analyses, factors unrelated to the outcome in univariate analyses (P . 0.20) were not introduced, whereas missing values were included as specific categories to maintain all subjects in the analysis; odds ratios for missing values are not shown. Selected interaction terms (ie, study site in relation to other dependent variables, maternal morbidity in relation to CD4 cell count, and infant morbidity in relation to HIV infection status at 6 weeks) were tested and retained in the final models if P , 0.20. The x 2 test or the Fisher exact test (as appropriate) was used for associations between 2 categorical variables. The duration of breastfeeding was analyzed using the Kruskal-Wallis test. SAS version 9.2 (Cary, NC) was used for the analysis, and tests were considered significant at P , 0.05.
RESULTS
Size and Characteristics of the Study Population
Of 1045 women who gave birth to a liveborn singleton, 1028 mother-infant pairs were present at 1 or more postnatal visits, and among them, 995 and 949 infants were still being followed by 3 and 6 months postpartum, respectively (see Figure S1 , Supplemental Digital Content, http://links.lww.com/QAI/A373).
Characteristics of study subjects varied in many aspects according to infant feeding choice in the neonatal period (ie, ever vs. never breastfeeding, Table 1 ). Women also differed strongly across study sites. Notably, their level of education and sanitation was considerably lower in Bobo-Dioulasso, whereas access to electricity was greater in the South African sites (P , 0.001 for all, data not shown).
Breastfeeding Duration and Mode
Seventy-six percent of women initiated breastfeeding (90.4%, 73.1%, 69.9%, 56.8%, and 80.0% for BoboDioulasso, Mombasa, Nairobi, Durban, and Somkhele, respectively, P , 0.0001). The median duration of any breastfeeding ( Fig. 1 ) was 5.1 months (interquartile range, 2.9-6.0), that is, 5.5 months (Bobo-Dioulasso), 3.1 months (Mombasa), 3.7 months (Nairobi), 6.0 months (Durban), and 5.2 months (Somkhele), respectively (P , 0.001). Among women who ever breastfed, 73.2%, 48.0%, and 10.5% continued breastfeeding at 3, 5, and 7 months postpartum, respectively ( Table 2) .
The median duration of EBF by study site was 3.4 (interquartile range, 0.8-5.1; Bobo-Dioulasso), 1.4 (0.4-3.1, Mombasa), 1.8 (1.2-2.6, Nairobi), 5.3 (1.6-6.0, Durban), and 4.5 (1.5-5.4, Somkhele), months respectively (P , 0.001). Among ever breastfeeding women, less than half breastfed exclusively by 3 months compared with 22% by 5 months (Table 2 ). In Bobo-Dioulasso and Mombasa, nearly one third of women practiced predominant breastfeeding at 1 month postpartum. Forty-two infants were determined to be HIV-1 infected by polymerase chain reaction at 6 weeks of age, 31 of whom were ever breastfed. In comparison with other children, feeding patterns were not different by 3 months (data not shown), but a larger proportion was breastfed beyond 7 months postpartum (53% vs. 9%, P , 0.001).
Determinants of Breastfeeding Initiation and Duration
In univariate analyses of breastfeeding initiation, virtually all variables examined (ie, study site, maternal primiparity, education, professional activity, fuel used for cooking, source of drinking water, toilet facilities, possession of a refrigerator, country-specific wealth tertile, CD4 cell count category at inclusion, disclosure of HIV infection status to partner, birth weight category, and mode of delivery) were associated with breastfeeding initiation with P # 0.20, with the exception of trial arm and infant gender (P . 0.70 for both). However, in multivariate modeling including adjustment for household characteristics important for safe preparation of breast milk substitutes (model 1, Table 3 ) or for the wealth index tertile (model 2, data not shown), only study site, maternal education, maternal CD4 cell count, and mode of delivery remained statistically significant. Specifically, living in one of the Kenyan sites or in Durban, having secondary school education or a CD4 count of less than 200 cells per cubic millimeter, and emergency cesarean delivery were independently associated with lower odds of breastfeeding initiation (Table 3) . No interaction terms were associated with P # 0.20.
In a subsample of 750 women with available data, partner disclosure was closely and independently associated with lower odds of breastfeeding initiation (model 3, Table 3 ).
In unadjusted analyses of breastfeeding at 3 months of age if breastfeeding at 1 month, all the above-mentioned variables except maternal CD4 cell count category at enrollment and maternal weight gain at 2-4 weeks postpartum were associated with breastfeeding continuation with P # 0.20 (Table 4) . In adjusted analyses, the probability of still being breastfed at age 3 months if breastfeeding at 1 month was significantly lower for infants in Mombasa, Nairobi, and Somkhele and for infants for whom mothers had reported neonatal morbidity, whereas maternal fever or fatigue in the first month postpartum tended to be associated with a lower probability (Table 4) . No interaction terms had P # 0.20.
Sensitivity analyses were conducted to ascertain that no onset of weaning had occurred before the 4-week visit, thereby reversing the direction of causality between breastfeeding cessation and infant morbidity. First, we excluded 11 infants: 2 whose weaning process had started on the day of the 4-week visit or on the previous day and 9 whose date of onset of weaning was missing (among those whose date of cessation was below 2 months). The adjusted odds ratio (aOR) for neonatal morbidity was unchanged, 0.57 (0.34-0.96). Using another approach, age at weaning was defined as the date of the last visit during which breastfeeding was still ongoing (hereby underestimating the "true" duration of breastfeeding). Among 691 included infants, 529 were still breastfeeding at age 3 months and the aOR for neonatal morbidity was 0.49 (0.31-0.80).
In unadjusted analyses of EBF at 3 months of age if EBF at 1 month, all variables examined except maternal occupation, weight gain, and morbidity during the neonatal period were associated with EBF continuation with P # 0.20. In adjusted analyses, study site, gender, and neonatal morbidity remained statistically significant. Specifically, those at Kenyan study sites, males and infants with neonatal morbidity were less likely to continue EBF (Table 4) .
DISCUSSION
This study investigated breastfeeding modes in a culturally diverse sample of 1028 HIV-1-infected sub-Saharan African women who were counseled to either totally avoid breastfeeding or breastfeed exclusively and cease early, that is, at 6 months or earlier if formula feeding was considered acceptable, feasible, sustainable, and safe.
One quarter of women formula fed from birth. Women who delivered by emergency cesarean delivery and those with a CD4 count ,200 cells per cubic millimeter at enrollment were considerably less likely to breastfeed. Infant feeding counselors probably emphasized the high risk of postnatal transmission to the latter. 16 Boys had lower odds of EBF by 3 months of age. The association was strong and consistent across study sites (results not shown). To our best knowledge, such an association with child gender has not been reported previously. It may be that mothers consider energy needs of boys to be greater to those of girls and are therefore more likely to introduce other foods early to the former (we have only anecdotic evidence from Mombasa for this hypothesis).
An individual patient data meta-analysis of late postnatal MTCT of HIV-1 in sub-Saharan Africa showed an increased risk among boys [aOR, 1.7 (1.1-2.5); P = 0.014].
The duration of breastfeeding did not differ according to gender, but breastfeeding mode could not be analyzed. Because partial breastfeeding is associated with an excess risk of MTCT compared with EBF, [17] [18] [19] these gender differences in MTCT might thus be explained by differences in the duration of EBF.
Neonatal morbidity (diarrhea, fever, and vomiting up till 4 weeks of age) was associated with greater odds of ceasing breastfeeding between 1 and 3 months of age. Considerable care was taken to the time sequence of events to avoid reverse causality. The excess risk of cessation of EBF between 1 and 3 months among ill neonates was also significant; thus, the Visits were conducted at 2, 4, 6, and 8 weeks and 3, 4, 5, 6, and 7 months. Breastfeeding definitions were based on recall since preceding visit. At the first occurrence of predominant or partial feeding, the child shifted category permanently. Feeding modes were significantly different across study sites from 1 to 7 months (P , 0.001).
*Data are missing for a few infants at all ages due to missed visits. †EBF: no foods or fluids other than breast milk, except for drugs and vitamins. ‡Predominant breastfeeding: breast milk and water-based fluids; partial breastfeeding: breast milk plus other fluids and/or foods, including formula. association was not due to more frequent non-EBF in neonates who were to be weaned from 1 to 3 months. To our best knowledge, such an association has not been reported previously. One prior study showed greater odds of breastfeeding cessation between 3 and 24 weeks for hospitalized HIV-exposed infants in 3 South African settings. 20 In the present study, we included all cases of routinely collected mother-recalled morbidity and only a small proportion was hospitalized (ie, 6/128, as per serious adverse event forms). Possibly, some mothers, already anxious about the risk of HIV-1 transmission through their breast milk, lose confidence in reaction to neonatal morbidity and decide to wean quickly. This finding needs confirmation in other studies; indeed, if confirmed, adjustment for preexisting infant morbidity would be necessary in the assessment of breastfeeding cessation as a risk factor for infant morbidity and mortality. 21 The risk of breastfeeding cessation by 3 months was lowest in Bobo-Dioulasso and greatest in Mombasa. These differences could be only in part explained by level of sanitation and socioeconomic status. National health policies probably also influenced counselors. Indeed, in 2007, the standard advice to HIV-1-infected women in Nairobi was to cease breastfeeding at 3 months postpartum. 22 In the 2 Kenyan study sites, information about the child's HIV-1 infection status was given at the 3-month visit, thus providing mothers of HIV-1-uninfected children an opportunity to stop breastfeeding. Both South African sites had high proportions of women with EBF up to 6 months; in these sites, information about the child's HIV-1 status at 5 months was given at a specific visit at 5.5 months postpartum. In those sites, the EBF rate was lower than in an intervention study in KwaZulu-Natal 23 but greater than in several other studies. 24, 25 Ceasing breastfeeding by 6 months seemed particularly difficult for Burkinabe women, despite free provision of a fortified infant food mix from 6 to 12 months.
14 Seventeen percent of those whose infants were HIV uninfected by 6 weeks of age still breastfed at 7 months, and several cases of weaning failure were registered due to family pressure. It is likely that weaning failures carry a high risk of MTCT due to a "rebound effect" of viral load in breast milk after breastfeeding cessation, 26 particularly after stopping ARVs. Important strengths of this analysis are the relatively large sample size and prospectively collected data at short intervals. One shortcoming, however, was that in the Burkinabe study site, infant feeding counselors were also in charge of the collection of infant feeding data. Thus, adherence to recommended practices (particularly EBF and breastfeeding cessation by 6 months) might have been overestimated.
Nevertheless, nearly one third of women in BoboDioulasso (and Mombasa) declared to have introduced nonbreast milk liquids by 1 month postpartum. Qualitative research conducted among study participants in Bobo-Dioulasso showed that many women felt it difficult to protect their child from being given water-based liquids by other family members. 27 Unfortunately, no qualitative research data were available for other study sites.
In late 2009, WHO recommended that breastfeeding among HIV-1-infected women who do not need antiretroviral therapy for their own health be covered by a combination of ARVs for prophylaxis, provided either to the child or to the mother until complete cessation. 28 Breastfeeding should be exclusive until 6 months and continued until 12 months postpartum. This major change in recommendations was prompted by a significant reduction in MTCT observed in several RCTs using ARV drugs as prevention, including the Kesho Bora Study. 15, 29, 30 It was also supported by recent evidence of the detrimental effects on child health and survival of short breastfeeding or no breastfeeding among HIV-1-infected African women. [31] [32] [33] The results of the present analysis emphasize the challenge of breastfeeding exclusively for 6 months in sub-Saharan Africa, despite strong incentives and careful repeated counseling to an extent, which is hardly feasible in routine health care.
In conclusion, qualitative research is needed to better understand maternal beliefs and perceptions to inform and readjust infant feeding counseling and support, with particular emphasis on boys and, possibly, ill neonates.
APPENDIX 1: The Kesho Bora Study Group
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